Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1

Table 6

Effects of HAD-B1 on minute volume in rats.

Groups	Dose (mg/kg)	Time (hr)
		0	1	2	4	6	24
Control	0	183.44l38.67	147.86l19.95	144.05l29.36	142.91l15.68	171.22l82.51	164.56l20.34
T1	500	174.77l60.05	148.36 ± 18.94	144.65 ± 18.9	136.74 ± 18.94	142.38 ± 18.94	201.24 ± 18.94
T2	1000	160.41 ± 18.94	170.56 ± 18.94	166.32 ± 18.94	140.82 ± 18.9	173.41 ± 18.94	211.70 ± 18.94
T3	2000	170.06 ± 18.94	157.98 ± 18.9	190.25 ± 18.94	142.61 ± 18.94	165.82 ± 18.94	176.01 ± 18.94

Note. Data described as the mean ± S.D. (n = 8).